Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardio Diagnostics Holdings (CDIO) EPS (Basic) (2021 - 2025)

Cardio Diagnostics Holdings' EPS (Basic) history spans 5 years, with the latest figure at -$0.98 for Q3 2025.

  • For Q3 2025, EPS (Basic) rose 43.35% year-over-year to -$0.98; the TTM value through Sep 2025 reached $6.14, up 165.53%, while the annual FY2024 figure was -$0.31, 53.03% up from the prior year.
  • EPS (Basic) for Q3 2025 was -$0.98 at Cardio Diagnostics Holdings, down from -$0.97 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $9.06 in Q4 2024 and bottomed at -$5.93 in Q1 2024.
  • The 5-year median for EPS (Basic) is -$0.28 (2023), against an average of -$0.32.
  • The largest YoY upside for EPS (Basic) was 8374.53% in 2024 against a maximum downside of 5382.64% in 2024.
  • A 5-year view of EPS (Basic) shows it stood at -$0.12 in 2021, then plummeted by 518.55% to -$0.77 in 2022, then surged by 85.78% to -$0.11 in 2023, then soared by 8374.53% to $9.06 in 2024, then crashed by 110.82% to -$0.98 in 2025.
  • Per Business Quant, the three most recent readings for CDIO's EPS (Basic) are -$0.98 (Q3 2025), -$0.97 (Q2 2025), and -$0.97 (Q1 2025).